Mark Silguero and Amy Wolfe v. Csl Plasma, Incorporated

579 S.W.3d 53
CourtTexas Supreme Court
DecidedJune 28, 2019
DocketNO. 18-1022
StatusPublished
Cited by99 cases

This text of 579 S.W.3d 53 (Mark Silguero and Amy Wolfe v. Csl Plasma, Incorporated) is published on Counsel Stack Legal Research, covering Texas Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mark Silguero and Amy Wolfe v. Csl Plasma, Incorporated, 579 S.W.3d 53 (Tex. 2019).

Opinion

Justice Green delivered the opinion of the Court.

In this opinion we consider two questions certified to this Court by the Fifth Circuit Court of Appeals: (1) Is a plasma collection center a "public facility" under Texas Human Resources Code (THRC) section 121.002(5), and if so, (2) what standard applies for determining whether a public facility's rejection of a person with a disability constitutes impermissible discrimination under the THRC? We hold that a plasma collection center is a "public facility" under section 121.002(5). We further hold that a plasma collection center may reject a person with a disability-eliminating their opportunity to donate plasma and receive compensation-without committing impermissible discrimination under section 121.003(a) when: (1) the plasma center's rejection does not meet the THRC's definition of "discrimination" or satisfies an exception to the definition of "discrimination," such as the application of eligibility criteria that screen out persons with disabilities, but are shown to be necessary for the provision of services; or (2) the defendant establishes that allowing the person with a disability full use and enjoyment of the public facility would pose a direct threat to the health or safety of others. See 42 U.S.C. § 12182 (b)(2)(A)(i), (b)(3).

I. Background

CSL Plasma, Inc. operates plasma collection centers across the United States. At these centers, CSL extracts the donor's blood, separates the donor's plasma from the red blood cells, and then returns the red blood cells to the donor's bloodstream. 1 After this extraction process, CSL compensates the donor, 2 processes the plasma to create a marketable plasma byproduct, and ultimately sells this byproduct to pharmaceutical companies. The federal Food and Drug Administration (FDA) regulates this plasma extraction process. The FDA licenses and audits plasma collection centers.

*56 Under the FDA's regulations, CSL must screen all potential donors to determine whether each individual is eligible to donate. See 21 C.F.R. § 630.10 . During the screening, potential donors answer health-related questions, and CSL's medical staff, referring to CSL's medical guidelines, determine their eligibility by checking their vital signs and considering their medical history, current medications, and whether they have recent tattoos. For example, CSL's medical guidelines on eligibility provide that if a potential donor suffers from anxiety requiring the use of a service dog, he or she is ineligible to donate. CSL's medical staff is permitted to contact CSL physicians to discuss particular potential donors. Individuals who fail the screening are deferred, meaning they are not permitted to donate and receive no compensation. Mark Silguero and Amy Wolfe were potential donors at CSL.

Silguero suffers from bad knees and uses a cane. CSL and Silguero agree that Silguero qualifies as a person with disabilities under the Americans with Disabilities Act (ADA) and the THRC. Silguero had previously donated plasma at CSL between January and April 2014. Silguero attempted to donate again on January 2, 2015. At that time, the condition of Silguero's knees had worsened to the point of needing knee replacements. Silguero went through CSL's donor-screening process, and CSL informed him that he would be deferred and unable to donate that day. Silguero claims he was deferred because of his "unsteady gait" and because CSL believed that he could not transfer safely to and from the donation bed. Silguero became upset, shook his finger at the medical staff, and told them they would be sorry. As a result, CSL deferred Silguero permanently, banning him from donating at CSL.

Wolfe suffers from an anxiety disorder and utilizes a service dog to improve her symptoms. Having never donated at CSL before, Wolfe went to CSL to donate plasma on October 9, 2016. Both CSL and Wolfe agree that Wolfe qualifies as a person with a disability under the ADA and the THRC. CSL did not allow Wolfe to donate because she required a service animal to treat her anxiety. In deferring her, CSL relied on its guidelines that a person is ineligible to donate if they suffer from anxiety requiring the use of a service dog.

Silguero filed suit against CSL in federal court on August 24, 2016, alleging unlawful discrimination on the basis of his disability. He sought injunctive relief under Title III of the ADA and both injunctive relief and damages under chapter 121 of the THRC. The district court allowed Wolfe to intervene as a plaintiff on March 28, 2017, because her claims against CSL for disability discrimination presented common questions of fact and law. On August 14, 2017, each side moved for summary judgment. CSL argued that it was neither a place of "public accommodation" under the ADA, because it did not qualify as a "service establishment," nor a "public facility" under the THRC. It further asserted that Silguero and Wolfe (collectively, the "plaintiffs") could not establish a genuine issue of material fact as to whether CSL fell under the ADA or THRC. The plaintiffs argued that a plasma collection center falls within the plain meaning of "service establishment" under the ADA because it is simply an establishment that provides a service. The plaintiffs cited a Tenth Circuit Court of Appeals case in support of this argument. See Levorsen v. Octapharma Plasma, Inc. , 828 F.3d 1227 , 1234 (10th Cir. 2016) (holding that a plasma collection center was a "service establishment" under the ADA). Under the THRC, the plaintiffs argued that a plasma collection center qualifies as a retail business and commercial establishment to which the general public is invited or, alternatively, *57 as an "other place of public accommodation."

The district court granted summary judgment in favor of CSL. No. 2:16-CV-361, 2017 WL 6761818 , at *1 (S.D. Tex. Nov. 3, 2017) (slip copy). The district court first concluded that a plasma collection center is not a place of "public accommodation" under section 12181(7) of the ADA. Id. at *4. The court reasoned that plasma collection centers are not "other service establishment[s]" under section 12181(7)(F) because they pay donors for their plasma rather than offering a service in exchange for compensation. Id.

Having decided that the ADA does not apply, the district court elected to maintain supplemental jurisdiction over the plaintiffs' state law claims. See id. at *5 (citing Baker v. Farmers Elec. Coop., Inc.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Butler v. Collins
Fifth Circuit, 2024
Daniel Villanueva v. RNA Financial LLC
Court of Appeals of Texas, 2024
Simpson v. Moore
105 F.4th 823 (Fifth Circuit, 2024)
Lubbock County v. Oscar Reyna
Court of Appeals of Texas, 2024

Cite This Page — Counsel Stack

Bluebook (online)
579 S.W.3d 53, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mark-silguero-and-amy-wolfe-v-csl-plasma-incorporated-tex-2019.